Replies to post #158215 on Biotech Values

[iwfal]

XOMA -

Presumably they have quite a bit of safty data from The unssuccesful diabetes trials. They have given the drug To quite a few people by now. Wouldnt the infection problem

I am sure that they do have data on the infection rate. But I have, literally, never seen a small biotech release safety data of this type. The first time investors hear about it is in the AdCom materials released by the FDA.